Molecular pathogenesis of squamous cell carcinoma

Cancer Treatment and Research

Volumn 146, Issue , 2009, Pages 205-211

  Nindl, Ingo ^a   Rösl, Frank ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; CARCINOGEN;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER RISK; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ANIMAL; BIOLOGICAL MODEL; CARCINOMA, SQUAMOUS CELL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MODELS, BIOLOGICAL; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

EID: 77953675055     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78574-5_18     Document Type: Review

References (36)

1. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1:795-7.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681-91.
3. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6:963-8.
4. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63:8-18.
5. Erb P, Ji J, Wernli M et al. Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol Lett 2005; 100:68-72.
6. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372:773-6.
7. Soufir N, Moles JP, Vilmer C et al. P16 UV mutations in human skin epithelial tumors. Oncogene 1999; 18:5477-81.
8. Kreimer-Erlacher H, Seidl H, Bäck B et al. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. J Invest Dermatol 2003; 120:676-82.
9. Saridaki Z, Liloglou T, Zafiropoulos A et al.Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 2003; 148:638-48.
10. Brown VL, Harwood CA, Crook T et al. p16 and p14 tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004; 122:1284-92.
11. Ananthaswamy HN, Pierceall WE. Molecular alterations in human skin tumors. Prog Clin Biol Res 1992; 376:61-84.
12. Popp S, Waltering S, Herbst C et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002; 99:352-60.
13. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005; 26:1657-67.
14. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-83.
15. Pierceall WE, Goldberg LH, Tainsky MA et al. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991; 4:196-202.
16. Corominas M, Kamino H, Leon J et al. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? Proc Natl Acad Sci U S A 1989; 86:6372-6.
17. Spencer JM, Kahn SM, Jiang W et al. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995; 131: 796-800.
18. Dooley TP, Reddy SP, Wilborn TW et al. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem Biophys Res Commun 2003; 306:1026-36.
19. Tilli CM, Ramaekers FC, Broers JL et al. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Br J Dermatol 2003; 148:102-9.
20. Nindl I, Dang C, Forschner T et al. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling. Mol Cancer 2006; 5:30.
21. Dang C, Gottschling M, Roewert J et al. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 2006; 155:763-70.
22. Going JJ. Epithelial carcinogenesis: challenging monoclonality. J Pathol 2003; 200:1-3.
23. Glick A, Ryscavage A, Perez-Lorenzo R et al. The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer. Mol Carcinog 2007; 46:605-10.
24. Balmain A, Harris CC. Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis 2000; 21:371-7.
25. Wu X, Pandolfi PP. Mouse models for multistep tumorigenesis. Trends Cell Biol 2001; 11:S2-S9.
26. Kemp CJ. Multistep skin cancer in mice as a model to study the evolution of cancer cells. emin Cancer Biol 2005; 15:460-73.
27. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992; 54:63-128.
28. Brown K, Quintanilla M, Ramsden M et al. v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 1986; 46:447-56.
29. Zoumpourlis V, Solakidi S, Papathoma A et al. Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis. Carcinogenesis 2003; 24:1159-65.
30. Darwiche N, Ryscavage A, Perez-Lorenzo R et al. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene 2007; 26:6885-95.
31. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999; 19:2435-44.
32. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072:129-57.
33. Rutberg SE, Saez E, Lo S et al. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Oncogene 1997; 15:1337-46.
34. Rutberg SE, Adams TL, Glick A et al. Activator protein 1 transcription factors are fundamental to v-ras-Ha-induced changes in gene expression in neoplastic keratinocytes. Cancer Res 2000; 60:6332-8.
35. Young MR, Li JJ, Rincon M et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 1999; 96:9827-32.
36. Gerdes MJ, Myakishev M, Frost NA et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 2006; 66:7578-88.